Other Clinical Trial - Skin Irritation Test of LEO 80185 Gel in Healthy

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

The purpose of the study is to investigate skin irritation of LEO 80185 gel, gel vehicle and Liquid Paraffin in healthy Japanese male subjects.

n/a

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04971200` - Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo	Early Phase 1
Active, not recruiting	`NCT05525741` - Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients	N/A
Completed	`NCT01093911` - Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)	Phase 1
Completed	`NCT00147511` - Time To Efficacy and Onset Of Action Of Linezolid	Phase 4
Completed	`NCT02355639` - A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin	Phase 1
Completed	`NCT01764594` - Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus	Phase 1
Active, not recruiting	`NCT05185258` - Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study	Phase 4
Completed	`NCT02985437` - Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin	Phase 1
Completed	`NCT02518048` - A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris	Phase 2
Withdrawn	`NCT03196115` - Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)
Completed	`NCT02416258` - A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)	Phase 2